National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 7620-7621 [2015-02754]
Download as PDF
<![CDATA[
7620
Federal Register / Vol. 80, No. 28 / Wednesday, February 11, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Adults—Biospecimen Collection: Blood ..........................................
Adults—Tobacco Use Form ............................................................
Adults—Follow-up/Tracking Participant Information Form ..............
Youth—Youth respondents at Wave 1 or Wave 2—Extended
Interview .......................................................................................
Youth—Shadow youth who age up to youth cohort at Wave 3—
Assent for Extended Interview .....................................................
Youth—Shadow youth who age up to youth cohort at Wave 3—
Extended Interview .......................................................................
Adult—Youth respondents at Wave 1 or Wave 2—Parent Interview ..............................................................................................
Adults—Parents of Shadow youth who age up to youth cohort at
Wave 3—Parent Permission and Consent for Parent Interview
Adults—Parents of Shadow youth who age up to youth cohort at
Wave 3—Parent Interview ...........................................................
Adults—Verification Interview ..........................................................
Adults—Validation Interview ............................................................
Adults—Follow-up/Tracking Participant Information Form for
Youth (completed by parents) ......................................................
Adults—Follow-up/Tracking Participant Information Form for sample Shadow youth (completed by parents) ..................................
Dated: February 5, 2015.
Genevieve deAlmeida-Morris,
Project Clearance Liaison, National Institute
on Drug Abuse, NIH.
[FR Doc. 2015–02832 Filed 2–10–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
Clinical Study Applications.
Date: March 20, 2015.
Time: 8:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications
VerDate Sep<11>2014
17:07 Feb 10, 2015
Jkt 235001
Number of
responses per
respondent
Number of
respondents
Type of respondent and instrument
1
1
2
18/60
4/60
8/60
261
971
7,315
9,515
1
32/60
5,075
2,420
1
3/60
121
1,912
1
42/60
1,338
9,705
1
14/60
2,265
2,420
1
5/60
202
1,950
35,564
3,613
1
1
1
17/60
2/60
4/60
553
1,185
241
11,427
2
8/60
3,047
2,401
2
8/60
640
Dated: February 5, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–02758 Filed 2–10–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Neurological Disorders and Stroke
Special Emphasis Panel, March 16,
2015, 08:00 a.m. to March 17, 2015,
06:00 p.m., Bethesda North Marriott
Hotel & Conference Center, Montgomery
County Conference Center Facility, 5701
Marinelli Road, North Bethesda, MD
20852 which was published in the
Federal Register on January 23, 2015,
80FRN3613.
Frm 00057
Fmt 4703
Total annual
burden hours
869
14,572
27,430
Place: National Institutes of Health, One
Democracy Plaza, Suite 800, 6701 Democracy
Boulevard, Bethesda, MD 20892.
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 814,
Bethesda, MD 20892, 301–451–4838 mak2@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
PO 00000
Average burden
per response
(in hours)
Sfmt 4703
The meeting has been changed to a
teleconference meeting. The date and
time remain the same. The meeting is
closed to the public.
Dated: February 5, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–02757 Filed 2–10–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Microbiology and Infectious Diseases
B Subcommittee.
E:\FR\FM\11FEN1.SGM
11FEN1
Federal Register / Vol. 80, No. 28 / Wednesday, February 11, 2015 / Notices
Date: March 2–3, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Ellen S. Buczko, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 5601
Fishers Lane, Rockville, 20892, 240–669–
5028, ebuczko1@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 4, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–02754 Filed 2–10–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group,
Biostatistical Methods and Research Design
Study Section.
Date: February 27, 2015.
Time: 11:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Fairmont Hotel San Francisco, 950
Mason Street, San Francisco, CA 94108.
Contact Person: Wenchi Liang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3150,
MSC 7770, Bethesda, MD 20892, 301–435–
0681, liangw3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–13–
080: Accelerating the Pace of Drug Abuse
Research Using Existing Data.
VerDate Sep<11>2014
17:07 Feb 10, 2015
Jkt 235001
Date: March 2, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Suzanne Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 435–
1712, ryansj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Topics in
Microbiology.
Date: March 3, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Fouad A El-Zaatari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
MSC 7808, Bethesda, MD 20892, (301) 435–
1149, elzaataf@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Radiation
Therapy and Biology SBIR/STTR.
Date: March 5–6, 2015.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Language and Communication.
Date: March 6, 2015.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3089B, MSC 7848, Bethesda,
MD 20892, (301) 402–4411, tianbi@
csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group,
Behavioral and Social Consequences of HIV/
AIDS Study Section.
Date: March 9–10, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave. NW., Washington, DC 20037.
Contact Person: Mark P. Rubert, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–806–
6596, rubertm@csr.nih.gov.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
7621
Name of Committee: AIDS and Related
Research Integrated Review Group,
Behavioral and Social Science Approaches to
Preventing HIV/AIDS Study Section.
Date: March 12–13, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Nikko Hotel, 222 Mason St., San
Francisco, CA 94102.
Contact Person: Jose H Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 5, 2015.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–02756 Filed 2–10–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group Diabetes,
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: March 3–4, 2015.
E:\FR\FM\11FEN1.SGM
11FEN1
]]>Agencies
[Federal Register Volume 80, Number 28 (Wednesday, February 11, 2015)]
[Notices]
[Pages 7620-7621]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-02754]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group; Microbiology and Infectious Diseases B
Subcommittee.
[[Page 7621]]
Date: March 2-3, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Ellen S. Buczko, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 5601 Fishers Lane,
Rockville, 20892, 240-669-5028, ebuczko1@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 4, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-02754 Filed 2-10-15; 8:45 am]
BILLING CODE 4140-01-P
